Most consumers at risk for heart disease either fail to look at the nutritional labels on their food or have trouble understanding them, according to a study presented this week at European Society of Cardiology (ESC) Congress 2018.

The FDA is mandating a new warning label on all sodium-glucose cotransporter-2 (SGLT2) inhibitors after the drugs were linked to 12 cases of Fournier’s gangrene in diabetic patients over the past five years.

Physicians estimate they’ll save 10,000 lives a year if sudden cardiac arrest patients are resuscitated with laryngeal tubes rather than conventional endotracheal intubation, according to a National Institutes of Health (NIH)-funded study published this month in the Journal of the American Medical Association.

Late-breaking results from the VISION study, presented early this week at the European Society of Cardiology (ESC)’s annual symposium, found nearly three-quarters of patient deaths after noncardiac surgery can be attributed to cardiovascular causes.

Less than two weeks after the FDA sent a warning letter to cardiologists about high mortality and stroke rates associated with SynCardia Systems’ Companion 2 (C2) Driver System, the company has published a response saying pre-implant risk factors were responsible for those outcomes.

Cardiac patients diagnosed with “broken heart syndrome” are twice as likely to run into clinical complications during treatment if they have a history of cancer, Italian researchers reported this week at the ESC Congress in Munich.

Research presented this week at the European Society of Cardiology Congress in Munich suggests a new treatment may be emerging for transthyretin amyloid cardiomyopathy—a condition previously thought to be rare and untreatable.

More middle-aged stroke survivors are able to afford their preventive medications under the Affordable Care Act (ACA), meaning fewer patients are at an increased risk for cardiovascular conditions like hypertension and diabetes, Reuters reported this week.